Investigator I (Formulation & Delivery / Nanoparticle)
- Employer
- CSL Behring
- Location
- Cambridge, Massachusetts
- Start date
- Nov 24, 2020
View more
- Discipline
- Science/R&D, Biotechnology
- Required Education
- Doctorate/PHD/MD
- Position Type
- Full time
Job Details
With operations in 35+ nations and ~27,000 employees worldwide, CSL is driven to develop and deliver a broad range of lifesaving therapies to treat disorders such as hemophilia and primary immune deficiencies, and vaccines to prevent influenza. Our therapies are also used in cardiac surgery, organ transplantation and burn treatment.
CSL is the parent company of CSL Behring and Seqirus. CSL Behring is a global leader in the protein biotherapeutics industry, focused on bringing to market biotherapies used to treat serious and often rare conditions. CSL Behring operates CSL Plasma, one of the world's largest collectors of human plasma, which is used to create CSL's therapies. Seqirus is one of the largest influenza vaccine companies in the world and is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally.
We invite you to take a look at the many career possibilities available around the globe and consider building your promising future at CSL by becoming a member of our team!
Job Description
Job Summary:
This Investigator is a responsible for development and performance of mRNA vaccine and adjuvanted protein vaccine formulation and delivery technology, to support vaccine discovery and development.
Major Responsibilities:
mRNA vaccine formulation and delivery development
- Development of delivery technology eg. Lipid nanoparticle, for efficient and safe delivery of mRNA vaccine.
- Development of mRNA vaccine formulation to improve vaccine stability.
Vaccine formulation to support vaccine development
- Development and performance of mRNA vaccine formulation, biophysical characterization and stability evaluation to support vaccine process development.
- Performance of mRNA vaccine and adjuvanted protein vaccine formulation to support vaccine preclinical development in animal models.
Documentation and presentation of scientific results
- Write experimental protocols and prepare internal reports. Maintain lab notebooks.
- Present research project progress within and beyond Research.
- Lead technical advancements and publications.
- Interact with cross-functional project teams and stakeholders as key contact.
- Interact with external collaborators as key contact.
Lab management
- Maintain functional laboratory equipment and follow HSE regulation.
Minimum Requirements:
- Ph.D. in Pharmaceutical Science, Chemistry, Biomedical engineering, Biochemistry or a related field
- 0-3 year academic or pharmaceutical/biotech experience in biologics formulation and delivery
- Strong knowledge and experience with nanoparticle fabrication and characterization is required.
- Strong knowledge and experience with medicinal chemistry especially lipid chemistry is required.
- Knowledge and experience with mRNA molecular biology and biochemistry are desired.
- Creative and the ability to generate accurate and reproducible results along with multi-tasking and working effectively in a fast-paced environment are critical.
- Strong organizational, written and oral communication skills and ability to work in teams is essential.
Company
As the third largest global biotechnology company with employees in more than 35 countries, CSL Behring is focused on serving patients with serious and rare diseases, including coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease and neurological disorders. We collaborate with patient and biomedical communities to improve access to therapies, advance scientific knowledge and support future medical research.
CSL Behring's dynamic environment fosters innovation and attracts the best and brightest who share a commitment to helping save lives. People here are free to live their Promising FUTURES where they can fulfill their individual career aspirations and realize their potential.
CSL Behring is committed to diversity and inclusion, both of which underpin our Values of patient focus, innovation, collaboration, integrity and superior performance. We believe that by harnessing and honoring the unique capabilities, experiences and perspectives of our people, we are better able to serve our patients.
CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. The parent company, CSL Limited, headquartered in Melbourne, Australia, employs more than 27,000 people, and provides its life-saving medicines in more than 70 countries.
For more information visit www.cslbehring.com. Help us deliver on our promise to save lives and protect the health of people around the world. Promising FUTURES start at CSL Behring!
Stock Symbol: CSL
Stock Exchange: Australian Securities Exchange
- Phone
- 610-878-4000
- Location
-
1020 First Avenue
King of Prussia
Pennsylvania
19406
United States
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert